Business
Guidance for Exchanging Ordinary Shares into ADSs
Guidance for Exchanging Ordinary Shares into ADSs.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3183F\n PureTech Health PLC\n 13 November 2020\n \n \n \n \n 13 November 2020\n \n \n PureTech Health plc\n \n \n \n \n \n PureTech Announces Instructions for Exchanging Listed\n \n \n Ordinary Shares into Nasdaq Listed ADSs\n \n \n \n \n \n PureTech Health plc\n (LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, today separately announced that in connection with a listing of American Depository Shares of the Company (\"ADSs\") on the Nasdaq Global Market (\"Nasdaq\"), the United States Securities and Exchange Commission has declared effective registration statements on Form 20-F and Form F-6 with respect to such securities. Each ADS represents 10 ordinary shares of the Company (\"Ordinary Shares\"). Nasdaq has approved the ADSs for listing, and the ADSs are expected begin trading on the Nasdaq Global Market under the symbol \"PRTC\" on 16 November 2020. \n \n \n \n \n \n This announcement is intended to guide holders of Ordinary Shares, which are admitted to trading on the main market of the London Stock Exchange, through the process of exchanging Ordinary Shares for ADSs, and to answer certain related frequently asked questions applicable to holders of the Ordinary Shares. For any further questions about the Ordinary Share to ADS exchange process, please contact the Company's ADS Depositary, Citibank, N.A.:\n \n \n \n \n \n \n \n \n New York\n \n \n Michael O'Leary / Jason Zoppel\n \n \n Email: [email protected]\n \n \n \n \n London\n \n \n Michael Woods \n \n \n Email: [email protected]\n \n \n \n \n \n \n \n \n This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.\n \n \n \n \n \n About PureTech Health\n \n \n PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intra...